These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 9501877)

  • 21. Genomic organization of the JEM-1 (BLZF1) gene on human chromosome 1q24: molecular cloning and analysis of its promoter region.
    Tong JH; Fant X; Benoit G; Chen SJ; Chen Z; Lanotte M
    Genomics; 2000 Nov; 69(3):380-90. PubMed ID: 11056056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and initial characterization of the 5' flanking region of the human and murine cyclic guanosine monophosphate-phosphodiesterase beta-subunit genes.
    Di Polo A; Bowes Rickman C; Farber DB
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):551-60. PubMed ID: 8595955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy.
    Gu SM; Thompson DA; Srikumari CR; Lorenz B; Finckh U; Nicoletti A; Murthy KR; Rathmann M; Kumaramanickavel G; Denton MJ; Gal A
    Nat Genet; 1997 Oct; 17(2):194-7. PubMed ID: 9326941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence and structure of the mouse gene for RPE65.
    Boulanger A; Liu S; Yu S; Redmond TM
    Mol Vis; 2001 Dec; 7():283-7. PubMed ID: 11740468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A homozygous deletion in RPE65 in a small Sardinian family with autosomal recessive retinal dystrophy.
    Poehner WJ; Fossarello M; Rapoport AL; Aleman TS; Cideciyan AV; Jacobson SG; Wright AF; Danciger M; Farber DB
    Mol Vis; 2000 Oct; 6():192-8. PubMed ID: 11062306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinal dystrophy of Swedish briard/briard-beagle dogs is due to a 4-bp deletion in RPE65.
    Veske A; Nilsson SE; Narfström K; Gal A
    Genomics; 1999 Apr; 57(1):57-61. PubMed ID: 10191083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cis-acting region associated with lung cell-specific expression of the secretory leukoprotease inhibitor gene.
    Kikuchi T; Abe T; Satoh K; Narumi K; Sakai T; Abe S; Shindoh S; Matsushima K; Nukiwa T
    Am J Respir Cell Mol Biol; 1997 Sep; 17(3):361-7. PubMed ID: 9308923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autosomal recessive retinal dystrophy associated with two novel mutations in the RPE65 gene.
    Marlhens F; Griffoin JM; Bareil C; Arnaud B; Claustres M; Hamel CP
    Eur J Hum Genet; 1998; 6(5):527-31. PubMed ID: 9801879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered expression of the transcription factor Mef2c during retinal degeneration in Rpe65-/- mice.
    Escher P; Schorderet DF; Cottet S
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5933-40. PubMed ID: 21715356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning and characterization of human and mouse telomerase RNA gene promoter sequences.
    Zhao JQ; Hoare SF; McFarlane R; Muir S; Parkinson EK; Black DM; Keith WN
    Oncogene; 1998 Mar; 16(10):1345-50. PubMed ID: 9546436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of basal promoter and enhancer elements in an untranslated region of the TT virus genome.
    Suzuki T; Suzuki R; Li J; Hijikata M; Matsuda M; Li TC; Matsuura Y; Mishiro S; Miyamura T
    J Virol; 2004 Oct; 78(19):10820-4. PubMed ID: 15367649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of upstream silencer elements involved in the expression of cone transducin alpha-subunit (GNAT2).
    Morris TA; Fong WB; Ward MJ; Hu H; Fong SL
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):196-206. PubMed ID: 9008644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression, purification, and MALDI analysis of RPE65.
    Ma J; Zhang J; Othersen KL; Moiseyev G; Ablonczy Z; Redmond TM; Chen Y; Crouch RK
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1429-35. PubMed ID: 11381042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of PRPF31 and TFPT: regulation in health and retinal disease.
    Rose AM; Shah AZ; Waseem NH; Chakarova CF; Alfano G; Coussa RG; Ajlan R; Koenekoop RK; Bhattacharya SS
    Hum Mol Genet; 2012 Sep; 21(18):4126-37. PubMed ID: 22723017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of syndecan-1 gene promoter during mouse tooth development.
    Iguchi-Ishiguro H; Ouchi Y; Watanabe S; Numabe Y
    Arch Oral Biol; 2012 May; 57(5):531-8. PubMed ID: 22134060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the VMD2 promoter and implication of E-box binding factors in its regulation.
    Esumi N; Oshima Y; Li Y; Campochiaro PA; Zack DJ
    J Biol Chem; 2004 Apr; 279(18):19064-73. PubMed ID: 14982938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the human beta(3)-adrenergic receptor gene in SK-N-MC cells is under the control of a distal enhancer.
    Susulic VS; LaVallette L; Duzic E; Chen L; Shuey D; Karathanasis SK; Steiner KE
    Endocrinology; 2001 May; 142(5):1935-49. PubMed ID: 11316759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional analysis of the promoter of the mitochondrial phosphate carrier human gene: identification of activator and repressor elements and their transcription factors.
    Iacobazzi V; Infantino V; Costanzo P; Izzo P; Palmieri F
    Biochem J; 2005 Nov; 391(Pt 3):613-21. PubMed ID: 15984930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the human alpha6 integrin gene promoter.
    Lin CS; Chen Y; Huynh T; Kramer R
    DNA Cell Biol; 1997 Aug; 16(8):929-37. PubMed ID: 9303435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of the human myeloperoxidase promoter.
    Austin GE; Zhao WG; Zhang W; Austin ED; Findley HW; Murtagh JJ
    Leukemia; 1995 May; 9(5):848-57. PubMed ID: 7769848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.